Sun Pharma slides 4% on report of Sebi ordering forensic audit

The audit has been ordered based on allegations of corporate governance and tax-related offences and securities market-related violations by the company

Sun Pharmaceutical Industries dipped 5 per cent to Rs 416.85 apiece in Wednesday's trade on the BSE after reports suggested that Securities and Exchange Board of India (Sebi) has ordered a forensic audit against the company to look into allegations of financial irregularities and lapses in corporate governance standards.

The audit has been ordered based on allegations made by a whistleblower in a 150-page complaint to Sebi, accusing Sun Pharma of committing corporate governance and tax-related offences and securities market-related violations.

Specifically, the whistleblower complained of a fund diversion of Rs 42,000 crore and of personal profits being made to